TABLE OF CONTENTS
1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 OVERVIEW OF NORTH AMERICA BIOSTIMULANTS MARKET 13
1.4 CURRENCY AND PRICING 14
1.5 LIMITATIONS 14
1.6 MARKETS COVERED 15
2 MARKET SEGMENTATION 17
2.1 MARKETS COVERED 17
2.2 GEOGRAPHICAL SCOPE 18
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 DBMR TRIPOD DATA VALIDATION MODEL 19
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.6 DBMR MARKET POSITION GRID 23
2.7 MULTIVARIATE MODELING 24
2.8 PRODUCT TIMELINE CURVE 25
2.9 SECONDARY SOURCES 26
2.10 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 29
5 REGULATORY SCENARIO 30
6 MARKET OVERVIEW 31
6.1 DRIVERS 33
6.1.1 INCREASIG NEED FOR SUSTAINABLE AGRICULTURE 33
6.1.2 UPSURGE IN THE DEMAND OF SEAWEEDS AS RAW MATERIAL 34
6.1.3 HIGH AGRICULTURAL PRODUCTION WORLDWIDE 34
6.1.4 HIGH DEMAND FOR ORGANIC FARMING 35
6.2 RESTRAINT 36
6.2.1 QUALITY ISSUE IN MANUFACTURING BIOSTIMULANTS 36
6.3 OPPORTUNITIES 36
6.3.1 RISING AWARENESS ABOUT BIOSTIMULANTS 36
6.3.2 STRATEGIC INITIATIVES BY ORGANIZATIONS 37
6.4 CHALLENGES 38
6.4.1 HIGH DEMAND OF SUBSTITUTE PRODUCTS 38
6.4.2 UNCERTAINTY IN BIOSTIMULANT REGULATION WORLDWIDE 38
7 NORTH AMERICA BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENTS 40
7.1 OVERVIEW 41
7.2 ACID BASED 42
7.2.1 AMINO ACID 43
7.2.2 HUMIC AND FULVIC ACIDS 43
7.3 EXTRACT BASED 43
7.3.1 SEAWEED EXTRACTS 44
7.3.2 PLANT EXTRACT 44
7.3.3 FUNGAL EXTRACT 44
7.4 PROTEIN HYDROLYSATES 44
7.5 MICROBIAL AMENDMENTS 44
7.6 CHITIN 45
7.7 CHITOSAN 45
7.8 B-VITAMINS 45
7.9 OTHERS 45
8 NORTH AMERICA BIOSTIMULANTS MARKET, BY CROP TYPE 46
8.1 OVERVIEW 47
8.2 FRUITS & VEGETABLES 48
8.3 CEREALS & GRAINS 48
8.4 OILSEEDS & PULSES 48
8.5 TURF & ORNAMENTALS 49
8.6 OTHER CROPS 49
9 NORTH AMERICA BIOSTIMULANTS MARKET, BY APPLICATION METHOD 50
9.1 OVERVIEW 51
9.2 FOLIAR TREATMENT 52
9.3 SOIL TREATMENT 52
9.4 SEED TREATMENT 52
10 NORTH AMERICA BIOSTIMULANTS MARKET, BY FORM 53
10.1 OVERVIEW 54
10.2 LIQUID 55
10.2.1 SOLUBLE LIQUID CONCENTRATE 55
10.2.2 EMULSIFIABLE CONCENTRATE 55
10.2.3 SUSPENSION CONCENTRATE 55
10.3 DRY 56
10.3.1 WETTABLE POWDER 56
10.3.2 DRY GRANULES 56
10.3.3 WATER DISPERSIBLE 56
11 NORTH AMERICA BIOSTIMULANTS MARKET, BY END USER 57
11.1 OVERVIEW 58
11.2 FARMERS 59
11.3 RELATED INDUSTRIES 59
11.4 RESEARCH INSTITUTES 59
12 NORTH AMERICA BIOSTIMULANTS MARKET, BY ORIGIN 60
12.1 OVERVIEW 61
12.2 NATURAL BIOSTIMULANTS 62
12.3 SYNTHETIC BIOSTIMULANTS 62
13 NORTH AMERICA BIOSTIMULANTS MARKET, BY DISTRIBUTION CHANNEL 63
13.1 OVERVIEW 64
13.2 DIRECT 65
13.3 INDIRECT 65
14 NORTH AMERICA BIOSTIMULANTS MARKET, BY COUNTRY 66
14.1 OVERVIEW 67
14.2 U.S. 73
14.3 CANADA 76
14.4 MEXICO 79
15 NORTH AMERICA BIOSTIMULANTS MARKET, COMPANY LANDSCAPE 82
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 82
16 COMPANY PROFILE 83
16.1 ADAMA LTD. 83
16.1.1 COMPANY SNAPSHOT 83
16.1.2 REVENUE ANALYSIS 84
16.1.3 COMPANY SHARE ANALYSIS 84
16.1.4 PRODUCT PORTFOLIO 85
16.1.5 RECENT DEVELOPMENT 85
16.2 SYNGENTA 86
16.2.1 COMPANY SNAPSHOT 86
16.2.2 REVENUE ANALYSIS 87
16.2.3 COMPANY SHARE ANALYSIS 87
16.2.4 PRODUCT PORTFOLIO 88
16.2.5 RECENT DEVELOPMENT 88
16.3 NOVOZYMES 89
16.3.1 COMPANY SNAPSHOT 89
16.3.2 REVENUE ANALYSIS 90
16.3.3 COMPANY SHARE ANALYSIS 90
16.3.4 PRODUCT PORTFOLIO 91
16.3.5 RECENT DEVELOPMENT 91
16.4 FMC CORPORATION 92
16.4.1 COMPANY SNAPSHOT 92
16.4.2 REVENUE ANALYSIS 93
16.4.3 COMPANY SHARE ANALYSIS 93
16.4.4 PRODUCT PORTFOLIO 94
16.4.5 RECENT DEVELOPMENT 94
16.5 EASTMAN CHEMICAL COMPANY 95
16.5.1 COMPANY SNAPSHOT 95
16.5.2 REVENUE ANALYSIS 96
16.5.3 COMPANY SHARE ANALYSIS 96
16.5.4 PRODUCT PORTFOLIO 97
16.5.5 RECENT DEVELOPMENTS 97
16.6 OMEX 98
16.6.1 COMPANY SNAPSHOT 98
16.6.2 PRODUCT PORTFOLIO 98
16.6.3 RECENT DEVELOPMENT 98
16.7 ACADIAN SEAPLANTS LIMITED 99
16.7.1 COMPANY SNAPSHOT 99
16.7.2 PRODUCT PORTFOLIO 99
16.7.3 RECENT DEVELOPMENT 99
16.8 AGRINOS 101
16.8.1 COMPANY SNAPSHOT 101
16.8.2 PRODUCT PORTFOLIO 101
16.8.3 RECENT DEVELOPMENT 101
16.9 ATLNTICA AGRICOLA 102
16.9.1 COMPANY SNAPSHOT 102
16.9.2 PRODUCT PORTFOLIO 102
16.9.3 RECENT DEVELOPMENTS 103
16.10 BAYER AG 104
16.10.1 COMPANY SNAPSHOT 104
16.10.2 REVENUE ANALYSIS 104
16.10.3 PRODUCT PORTFOLIO 105
16.10.4 RECENT DEVELOPMENTS 105
16.11 BIOLCHIM SPA 106
16.11.1 COMPANY SNAPSHOT 106
16.11.2 PRODUCT PORTFOLIO 106
16.11.3 RECENT DEVELOPMENTS 107
16.12 BRANDT CONSOLIDATED, INC. 108
16.12.1 COMPANY SNAPSHOT 108
16.12.2 PRODUCT PORTFOLIO 108
16.12.3 RECENT DEVELOPMENT 108
16.13 HAIFA GROUP 109
16.13.1 COMPANY SNAPSHOT 109
16.13.2 PRODUCT PORTFOLIO 109
16.13.3 RECENT DEVELOPMENT 109
16.14 ISAGRO 110
16.14.1 COMPANY SNAPSHOT 110
16.14.2 REVENUE ANALYSIS 111
16.14.3 PRODUCT PORTFOLIO 111
16.14.4 RECENT DEVELOPMENT 112
16.15 ITALPOLLINA S.P.A. 113
16.15.1 COMPANY SNAPSHOT 113
16.15.2 PRODUCT PORTFOLIO 113
16.15.3 RECENT DEVELOPMENTS 114
16.16 KOPPERT BIOLOGICAL SYSTEMS 115
16.16.1 COMPANY SNAPSHOT 115
16.16.2 PRODUCT PORTFOLIO 115
16.16.3 RECENT DEVELOPMENT 116
16.17 LALLEMAND INC. 117
16.17.1 COMPANY SNAPSHOT 117
16.17.2 PRODUCT PORTFOLIO 117
16.17.3 RECENT DEVELOPMENTS 118
16.18 MICROMIX 119
16.18.1 COMPANY SNAPSHOT 119
16.18.2 PRODUCT PORTFOLIO 119
16.18.3 RECENT DEVELOPMENT 119
16.19 TRADE CORPORATION INTERNATIONAL 120
16.19.1 COMPANY SNAPSHOT 120
16.19.2 PRODUCT PORTFOLIO 120
16.19.3 RECENT DEVELOPMENT 121
16.20 UPL 122
16.20.1 COMPANY SNAPSHOT 122
16.20.2 REVENUE ANALYSIS 122
16.20.3 SOLUTION PORTFOLIO 123
16.20.4 RECENT DEVELOPMENT 123
16.21 VALAGRO SPA 124
16.21.1 COMPANY SNAPSHOT 124
16.21.2 PRODUCT PORTFOLIO 124
16.21.3 RECENT DEVELOPMENTS 125
17 QUESTIONNAIRE 126
18 RELATED REPORTS 129

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.